Nipple-Areola Complex Sensitivity After the Section of Periareolar Dermis in Breast Reduction

NCT ID: NCT01789450

Last Updated: 2013-04-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the feasibility and sensitivity of nipple-areolar complex (NAC) prospectively due to the section of the dermis after decortication (Schwartzmann's maneuver), in 50 patients undergoing breast reduction surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Preservation of the dermis after decortication regions of the areola and periareolar is considered relevant by most plastic surgeons.

In patients whose CAP should be mobilized through large distances in order to correct breast ptosis, or in cases of dense breasts where noted little slip of skin over the breast parenchyma, the periareolar dermis causes limitation on the mobility of the NAC.

In clinical practice, there is a greater mobilization of NAC when making a careful section of the dermis after decortication. In contrast, the appearance of partial necrosis in these cases has become a rarity, as no case of total necrosis was observed.

Given the technical benefit observed due to greater mobilization, there is no report in the literature about how behaves the sensitivity of the NAC in these cases.

To evaluate the sensitivity of the NAC will be used Semmes-Weisnstein's monofilament. Each point will be obtained five measurements. The largest will be scorned and the lowest value. The final value of each point corresponds to an arithmetic mean of the three remaining values.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sensitivity of Nipple-areolar Complex

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Section of Periareolar Dermis

Section of Periareolar Dermis

Group Type EXPERIMENTAL

Section of Periareolar Dermis in Breast Reduction.

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Section of Periareolar Dermis in Breast Reduction.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sensitivity Nipple-Areolar Complex (NAC) Breast Reduction Schwartzmann's Maneuver Decortication

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who willingly seek the service requesting breast reduction or mastopexy;
* Patients who after consultation with the surgeon who led the research presents realistic expectation, being safe with the possible outcome of the surgery;
* Patients who undertake to comply with the protocol previously presented and discussed with them;

Exclusion Criteria

* Patients with prior breast surgery;
* Patients with body mass index (BMI) greater than 34.9;
* Patients with severe anemia;
* Patients with neurological disease;
* Patients with impairment cardiovascular;
* Metabolic diseases - diabetes;
* Patients with autoimmune disease;
* Menopausal patients
* Patients with collagen disease;
* Patients with psychiatric disorders.
Minimum Eligible Age

21 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidade Federal de Pernambuco

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jairo Zacchê de Sá

Jairo Zacchê de Sá

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jairo Z Sá, surgeon

Role: PRINCIPAL_INVESTIGATOR

Hospital das Clínicas da Universidade Federal de Pernambuco

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital das clínicas da UFPE

Recife, Pernambuco, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jairo Z Sá, surgeon

Role: CONTACT

81 34675717 ext. +55

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jairo Z Sá, surgeon

Role: primary

81 34675717 ext. +55

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UFPE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nipple Neurotization
NCT05897463 COMPLETED
Split Chest Breast Neurotization
NCT05757778 ACTIVE_NOT_RECRUITING NA
Therapeutic Nipple Sparing Mastectomy.
NCT02311959 COMPLETED PHASE3